SCHEMBL26361027

SCHEMBL26361027

CO[C@H]1OC(C(O)CO)[C@@H](C)[C@H](C)C1OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SSTR1 P30872 1/20 0.41
SSTR2 P30874 1/20 0.41
SSTR4 P31391 1/20 0.41
SSTR3 P32745 1/20 0.41
SSTR5 P35346 1/20 0.41
BCHE P06276 4/20 0.40
HTT P42858 3/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PTPN1 P18031 3/20 0.36
CDC25B P30305 1/20 0.36
LGALS8 O00214 1/20 0.36
PDPK1 O15530 1/20 0.35
MTOR P42345 1/20 0.35
PTPN2 P17706 2/20 0.35
MAPT P10636 1/20 0.35
CYP2C19 P33261 1/20 0.35
SLC6A2 P23975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15437475 1.00 SSTR1 (0.41) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL15437602 0.90 SSTR1 (0.41) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL26361053 0.90 SSTR1 (0.41) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL26361032 0.90 SSTR1 (0.41) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7152284 0.89 SSTR1 (0.46) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7151934 0.89 SSTR1 (0.46) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7151941 0.89 SSTR1 (0.46) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7153007 0.89 SSTR1 (0.46) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7152290 0.89 SSTR1 (0.46) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7156237 0.89 SSTR1 (0.46) SSTR1SSTR2SSTR4SSTR3SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11840551-B2 Compositions and methods of modulating the immune response by activating alpha protein kinase 1 SHANGHAI YAO YUAN BIOTECHNOLOGY CO., LTD. (CN) 2023-12-12 US disclosed
US-11773131-B2 Compositions and methods of modulating the immune response by activating alpha protein kinase 1 SHANGHAI YAO YUAN BIOTECHNOLOGY CO., LTD. (CN) 2023-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11840551-B2 Compositions and methods of modulating the immune response by activating alpha protein kinase 1 PHKA1, PHKA2, PRKCA SSTR1 4565/4885SSTR2 4724/4885SSTR4 4821/4885
US-11773131-B2 Compositions and methods of modulating the immune response by activating alpha protein kinase 1 PHKA1, PHKA2, PRKCA SSTR1 4565/4885SSTR2 4724/4885SSTR4 4821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.